Vimarsana
Biggest News Aggregation in the World

Page 4 - Nasdaq Sctl News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq Sctl. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Sctl Today - Breaking & Trending Today

Societal CDMO Announces U.S. FDA Approval for Manufacturing - Vimarsana News

Societal CDMO Announces U.S. FDA Approval for Manufacturing

Represents Societal CDMO’s First Commercially Manufactured Tablet Product, Expanding Beyond Expertise in Commercial Capsules...

Societal CDMO to Report Financial Results for Fourth - Vimarsana News

Societal CDMO to Report Financial Results for Fourth

Webcast Scheduled for Wednesday, March 1, 2023, at 4:30 p.m. Eastern SAN DIEGO and GAINESVILLE, Ga., Feb. 22, 2023 (GLOBE NEWSWIRE) -- Societal CDMO,...

Societal CDMO Announces Closing of $35.6 Million Concurrent - Vimarsana News

Societal CDMO Announces Closing of $35.6 Million Concurrent

EXTON, Pa., Dec. 14, 2022 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal”; NASDAQ: SCTL), a contract development and manufacturing organization...

Societal CDMO Announces Pricing of $35.6 Million Concurrent - Vimarsana News

Societal CDMO Announces Pricing of $35.6 Million Concurrent

EXTON, Pa., Dec. 12, 2022 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal”; NASDAQ: SCTL), a contract development and manufacturing organization...

Societal CDMO (SCTL) & Its Competitors Critical Contrast - Vimarsana News

Societal CDMO (SCTL) & Its Competitors Critical Contrast

Societal CDMO (NASDAQ:SCTL – Get Rating) is one of 938 publicly-traded companies in the “Pharmaceutical preparations” industry, but how does it weigh in compared to its peers? We will compare Societal CDMO to related businesses based on the strength of its valuation, profitability, dividends, institutional ownership, analyst recommendations, risk and earnings. Volatility and Risk Societal […]